Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2000
12/27/2000EP1062363A1 Method for producing agents for treating tumour diseases and for immunosuppression
12/27/2000EP1062332A2 Human receptor proteins; related reagents and methods
12/27/2000EP1062326A1 Glycosyl sulfotransferase-3
12/27/2000EP1062323A2 Methods of diagnosis and triage using cell activation measures
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062215A1 Antagonists of gonadotropin releasing hormone
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061951A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
12/27/2000EP1061949A1 Use of cytokines and mitogens to inhibit graft versus host disease
12/27/2000EP1061944A2 Therapeutic chemokine receptor antagonists
12/27/2000EP1061903A1 Delivery system to modulate immune response
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP1022278A4 Tetracyclical derivatives from pyrimidine
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0821666B1 Derivatives of succinamide and their use as metalloproteinase inhibitors
12/27/2000EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
12/27/2000CN1278299A Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
12/27/2000CN1278262A Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic
12/27/2000CN1278183A Soluble MHC complexes and methods of use thereof
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059800C Injection containing ginseng and astragalus root components
12/26/2000US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166087 Immunosuppresants, antiinflammatory agents, antitumor agents;applying to mucous membranes
12/26/2000US6166077 Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166060 Antihistamines; sleep disorders; central nervous system disorders
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165995 Cyclodextrin derivative in oil and water emulsion, said derivative substituted by at least one but no more than n-1 alkylacyl and alkenylacyl groups of linear hydrocarbon chains of at least eight carbon atoms and one sulfate group
12/26/2000US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines
12/26/2000US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same
12/26/2000US6165466 Antagonists of interleukin-15
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000CA2014885C 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
12/21/2000WO2000077517A1 Protein localization assays for toxicity and antidotes thereto
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077186A2 Bacterial protection against stress
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077046A1 A male-specific protein homologue involved in histocompatability
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077033A1 Retro-inverso peptides derived from interleukin-6
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000076982A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
12/21/2000WO2000076550A2 Carrier-drug conjugate
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076541A1 Pneumococcal surface protein combination vaccine
12/21/2000WO2000076539A2 A method to improve protective immunity induced by polynucleotide vaccines
12/21/2000WO2000076537A2 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076522A1 Administration of non-oral androgenic steroids to women
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076319A1 Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045834A3 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000040701A3 Non-myeloablative tolerogenic treatment
12/21/2000WO2000036421A8 Use of vascular endothelial growth factor (vegf)
12/21/2000CA2412345A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 1172